Mouwasat Medical Services Co (SAU:4002) ROCE %: 16.25% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SAU:4002 Mouwasat Medical Services Co SAU:4002
100 GF Score
Price ﷼60.90
GF Value ﷼109.50
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Mouwasat Medical Services Co ROCE %?

Mouwasat Medical Services Co SAU:4002 +0.25% 100 ROCE % is 16.25% as of Mar. 2026. GuruFocus rates SAU:4002 with a GF Score™ of 100/100 and a GF Value™ of ﷼109.50 (Significantly Undervalued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Mouwasat Medical Services Co's annualized ROCE % for the quarter that ended in Mar. 2026 was 16.25%.

Mouwasat Medical Services Co  (SAU:4002) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Mouwasat Medical Services Co ROCE % Related Terms

Mouwasat Medical Services Co ROCE % Historical Data

* Premium members only.

The historical data trend for Mouwasat Medical Services Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mouwasat Medical Services Co ROCE % Chart

Mouwasat Medical Services Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.66 18.68 19.27 17.01 18.99

Mouwasat Medical Services Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.94 17.73 17.88 20.53 16.25
SAU:4002
100GF Score
Mouwasat Medical Services Co SAU:4002
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mouwasat Medical Services Co ROCE % Calculation

Mouwasat Medical Services Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=902.725/( ( (5402.8 - 881.078) + (5986.267 - 999.459) )/ 2 )
=902.725/( (4521.722+4986.808)/ 2 )
=902.725/4754.265
=18.99 %

Mouwasat Medical Services Co's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=841.992/( ( (5986.267 - 999.459) + (6526.145 - 1148.337) )/ 2 )
=841.992/( ( 4986.808 + 5377.808 )/ 2 )
=841.992/5182.308
=16.25 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 16.25% mean?
Mouwasat Medical Services Co (SAU:4002) has a ROCE % of 16.25% as of Mar. 2026.
Is Mouwasat Medical Services Co's ROCE % too high?
Mouwasat Medical Services Co's current ROCE % is 16.25%. The Healthcare Providers & Services industry median ROCE % is 6.37. Mouwasat Medical Services Co's value of 16.25% is 155.1% above this industry median. Overall, Mouwasat Medical Services Co has a GF Score™ of 100/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mouwasat Medical Services Co's ROCE % compare to HCA and THC?
Mouwasat Medical Services Co's ROCE % of 16.25% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.37. Mouwasat Medical Services Co's value of 16.25% is 155.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.37, based on 645 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mouwasat Medical Services Co's current ROCE % of 16.25% is 155.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mouwasat Medical Services Co's current ROCE % is 16.25%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mouwasat Medical Services Co stock overvalued right now?
Based on GuruFocus' analysis, Mouwasat Medical Services Co (SAU:4002) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼109.50, compared to a current price of ﷼60.90 — trading 44.4% below its estimated fair value. The current ROCE % is 16.25% and 155.1% above the Healthcare Providers & Services industry median of 6.37. Mouwasat Medical Services Co's overall GF Score™ is 100/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Mouwasat Medical Services Co (SAU:4002), the current ROCE % is 16.25% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mouwasat Medical Services Co (SAU:4002) Overvalued in 2026?

Based on GuruFocus' analysis, Mouwasat Medical Services Co stock appears to be undervalued. The current stock price of ﷼60.90 is trading 44.4% below its estimated GF Value™ of ﷼109.50. GuruFocus considers Mouwasat Medical Services Co to be Significantly Undervalued.

Key valuation signals for SAU:4002:

  • ROCE %: 16.25%
  • GF Value™: ﷼109.50 vs. price of ﷼60.90 (44.4% below fair value)
  • GF Score™: 100/100 with 5 warning signs
  • Industry Position: 155.1% above the Healthcare Providers & Services median

No single metric tells the full story. See the SAU:4002 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mouwasat Medical Services Co Business Description

Address Destect 71, King Fahad Road, P.O. Box 282, Dammam, SAU, 31411
Mouwasat Medical Services Co is engaged in the acquisition, management, operation, and maintenance of hospitals, medical centers, drug stores, pharmacies, and wholesale of medical equipment and drugs. The company also operates skin care centers that offer clinical and cosmetic dermatology, aesthetic and reconstructive plastic surgery, weight reduction, and esthetician services. It operates in two segments Medical Services segment and Pharmaceuticals out of which the Medical Services segment derives the majority of revenue. The Medical Services segment includes Inpatient and outpatient services. The company provides specialized centers: Eye Center, Robotic Surgeries Center, Diabetes Center, Fertility Unit, Cardiology Center, Stroke Unit, Long Term Care Center, Obesity Center, and others.
100GF Score

Get the complete analysis for SAU:4002

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼60.90
Price
﷼109.50
GF Value